Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Non-Current Assets (2016 - 2017)

Bone Biologics (BBLG) has disclosed Non-Current Assets for 2 consecutive years, with $170.0 as the latest value for Q3 2017.

  • On a quarterly basis, Non-Current Assets fell 39.72% to $170.0 in Q3 2017 year-over-year; TTM through Sep 2017 was $824.0, a N/A change, with the full-year FY2016 number at $242.0, changed N/A from a year prior.
  • Non-Current Assets was $170.0 for Q3 2017 at Bone Biologics, down from $194.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $362.0 in Q1 2016 to a low of $170.0 in Q3 2017.